INBS — Intelligent Bio Solutions Share News
0.000.00%
Last trade - 00:00- $5.27m
- $1.06m
- $4.22m
Brief: Intelligent Bio Solutions Partners With Cliantha Research To Conduct Clinical Study As Part Of FDA 510(K) Pathway
Brief: Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal Second Quarter And Six-Month Revenue Results
Brief: Intelligent Bio Solutions Announces Reverse Stock Split
Brief: Intelligent Bio Solutions Receives Nata Accreditation For Its Revolutionary Fingerprint Sweat Drug Screening System
Brief: Intelligent Bio Solutions Inc Entered Into Underwriting Agreement
Brief: Intelligent Bio Solutions Completes Critical Development Milestone In Plans To Add Ketamine And Tramadol To Fingerprint Drug Test
Brief: Intelligent Bio Solutions Signs South American Distribution Agreement With TSCOM For Fingerprint Drug Screening System And Secures First Order
Brief: Intelligent Bio Solutions Receives Guidance From U.S. FDA On A Regulatory Pathway For U.S. Expansion Of Its Intelligent Fingerprinting Drug Screening Cartridge
Brief: Ma-Ran Foundation Reports 12.3% Stake In Intelligent Bio Solutions As Of May 12
Brief: Intelligent Bio Solutions Plans To Add Fentanyl Testing
U.S. STOCKS ON THE MOVE-DXP Enterprises, Holley, Augmedix
U.S. STOCKS ON THE MOVE-Arlo Technologies, Old Republic, Clearmind Medicine
U.S. STOCKS ON THE MOVE-GSK, Fox Corp, First Solar
Intelligent Bio jumps on higher Q3 revenue, expansion plans
Brief: Intelligent Bio Solutions Inc Reports Fiscal 2023 Third Quarter Financial Results And Operational Highlights
Brief: Intelligent Bio Solutions Secures Uk Patent For Intelligent Fingerprinting Dsr-Plus Cartridge Reader
Brief: Intelligent Bio Solutions Selects HASTA Lab As Drug Testing Specialist
Brief: Intelligent Bio Solutions Inc. Announces Closing Of $2.55 Million Public Offering And Full Exercise Of The Underwriters’ Option To Purchase Additional Shares And Warrants
U.S. STOCKS ON THE MOVE-Southwest Gas, Vertex, Viridian Therapeutics